Could a common blood thinner help fight ovarian cancer?

NCT ID NCT05284552

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether adding the blood thinner tinzaparin to standard chemotherapy can improve outcomes for women with advanced ovarian cancer. About 40 participants will receive either chemotherapy plus tinzaparin or chemotherapy alone. The main goal is to see if tinzaparin affects a key tumor marker called CA-125.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Tinzaparin (Innohep), a blood thinner
What this could lead to
If it works, this could point toward a way to make chemotherapy more effective for advanced ovarian cancer.
What could go wrong
This is a very small, early pilot study. It may not show a clear benefit, and the blood thinner carries a risk of bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Obstetrics and Gynaecology, Norrland University Hospital

    RECRUITING

    Umeå, Umeå, 90719, Sweden

  • Department of Obstetrics and Gynecology, Highland Hospital

    RECRUITING

    Eksjö, Eksjö, 575 81, Sweden

  • Department of Obstetrics and Gynecology, Ryhov County Hospital

    RECRUITING

    Jönköping, Jönköping County, 55305, Sweden

  • Department of Obstetrics and Gynecology, University Hospital

    ACTIVE_NOT_RECRUITING

    Linköping, Östergötland County, 58185, Sweden

  • Department of Obstetrics and Gynecology, Värnamo Hospital

    RECRUITING

    Värnamo, Värnamo, 33152, Sweden

  • Department of Obstetrics and Gynecology, Västervik Hospital

    RECRUITING

    Västervik, Västervik, 593 81, Sweden

  • Department of Oncology, Linköping University Hospital

    RECRUITING

    Linköping, Linköping, 58185, Sweden

  • Department of Oncology, Sahlgrenska University Hospital

    RECRUITING

    Gothenburg, Gothenburg, 41345, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.